Navigation Links
Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles 'Snuffy' Myers Announces Vitamin D Clinical Trials
Date:4/16/2008

CHARLOTTESVILLE, Va., April 16 /PRNewswire-USNewswire/ -- The Foundation for Cancer Research and Education (FCRE) announced today that prostate cancer oncologist and survivor, Dr. Charles "Snuffy" Myers, will lecture on new treatments for prostate cancer at Westminster at Lake Ridge, VA on April 26, 2008 from 9:30 AM--12:30 PM.

"With the recent press around prostate cancer vaccines, people are very excited about new treatments," Myers says. "The good news is there are many things people can do to prevent recurrence before it starts."

Some of those treatments include:

-- Celebrex

-- Proscar/Avodart

-- Leukine

-- Calcitriol

-- Avastin

-- Mediterranean heart healthy diet

-- Vitamin D3

-- Pomegranate.

In addition, to his lecture, Dr Myers will also be announcing his new clinical trials meant to investigate one of the most promising of those treatments -- vitamin D3.

"The current research and what I see in my patients suggests that vitamin D can dramatically slow the PSA doubling times that indicate recurrent and often lethal disease," Myers says. "The trials are meant to show Vitamin D3's role in slowing or stopping the growth of prostate cancer that has recurred after surgery or radiation in a much more substantive way." Information about the trial and how to participate will be provided at the meeting.

The program, located at Westminster at Lake Ridge, 12191 Clipper Drive, Lake Ridge or Woodbridge, VA, is free of charge and includes a heart-healthy buffet breakfast for all attendees. Sponsors include FCRE, The Virginia Prostate Cancer Coalition, Us TOO, Westminster at Lake Ridge, and Potomac Hospital.

This will be the fourth time Myers has presented at Lake Ridge but the first time he publicly announces the foundation's new research efforts.

"Myers's always provides informative lectures," notes Richard Gillespie, head of the Lake Ridge Us TOO Chapter. "But we're eager to hear about the new trials Dr. Myers is working on."

For information on the event or directions please call Richard Gillespie at 703-497-0628.

About FCRE

The Foundation for Cancer Research and Education (FCRE) is dedicated to cutting edge research and clinically driven educational programs. A streamlined organization with specific research goals, FCRE's mission is to prolong patients' lives with focused research strategies. For more information or for a list of FCRE's outreach programs call 800-305-2432 or go to http://www.cancer-foundation.org.


'/>"/>
SOURCE Foundation for Cancer Research and Education
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
3. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
6. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
11. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
Breaking Medicine News(10 mins):